Prismatic Advisory

Prismatic Advisory is listed as a small consultant research supplier in the Scientist.com network, with 1 site in 1 country.

Email me this page as a PDF

Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Sites 1

Countries 1

Type of company: Small consultant

Orphan Disease Consulting FDA requires that an Investigational Review Board (IRB) must review all the documents related to the inclusion of participants within clinical trials. IRB is expected to review all the research documents...

RWE/HEOR Data Science and Modeling A process that helps make sense of your clinical data
RWE/HEOR Drug/Therapy Discontinuation Analysis An analysis to understand patient behavior. Are the drugs taken on time, do the patients discontinue use, and if so how long after starting, etc.
RWE/HEOR Market Analysis A process to understand how a drug is performing in the market and possible opportunities in the market

Burden of Illness/Disease Strategy and study related to assessing the impact (economic, non-economic) of disease on health outcomes in a country, region, community, patient, or health system.
Cost Benefit Analysis Economic evaluation in which costs and benefits (outcomes) are expressed in monetary units, to determine if the benefits of an intervention outweigh the costs.
Health Economics and Outcomes Research (HEOR) Evaluate data collected during drug development to maximize the value of a therapeutic product.
Systematic Literature Review Summarizes the results of research (that meet pre-defined eligibility criteria for inclusion) and provides a high level of evidence on the outcomes assessed.

Health Technology Assessment (HTA) Preparation/Strategy Dossier Development Perform evidence preparation and/or create strategies for the systematic evaluation of the properties, effects, and/or impacts of health care technology.
Market Access - HTA Landscape Assessment Conduct a HTA landscape assessment to evaluate the direct and indirect impact of health technology on a specific region.
Market Access Materials Find general strategies and methods used to market a pharmaceutical product or device.
Pricing Strategy Develop value story tailored to a payer audience that will determine the appropriate price for treatment.
Value Based Agreements or Outcomes-Based Contracts Collaborate with payer or provider to develop a reimbursement plan outside of the traditional fixed cost-per-unit that ties reimbursement or price to actual health outcomes.
Value Dossiers Development Summary document that presents clinical, economic, and humanistic value of an intervention and associated disease state with the supporting evidence, formulated from the perspective of a particular stakeholder...

Show all 28 services 14 more

HEOR/Value Publications Writing and submission of manuscripts and abstracts focusing on Health Economics and Outcomes Research (HEOR) data, which demonstrate the economic and value proposition of a therapy.
Literature Monitoring Ongoing, systematic surveillance and analysis of published scientific literature to track emerging data, competitor activities, and changes in clinical understanding.
Medical Literature Reviews Systematic searching, appraisal, and synthesis of published scientific literature to generate evidence-based reports on a specific topic, disease, or treatment.

Payer and HTA Expectations Research Engages payers and HTA bodies to uncover evidence needs, pricing thresholds, and access drivers. Informs clinical and economic evidence generation planning.
Positioning and Value Proposition Testing Tests various positioning statements and value messages with target audiences. Refines messaging to maximize resonance and differentiation.

Claims Data & Database Analysis Analysis of care cost and quality.
Claims Data - Medical Includes hospitalization,physician visits,emergency department visits. May or may not include laboratory information including resource utilization, costs or charges, as well as ICD-9 or 10 codes.
Quantitative or Qualitative Research Either to understand concepts, thoughts, or experiences with qualitative research or to quantify the problem by generating numerical data or data that can be transformed into usable statistics with quantitative research.
Real World Evidence (RWE) Studies Studies (prospective or retrospective) utilizing data obtained from "real world settings" , and is outside the tight controls of a clinical trial design.
Real-World Evidence Acquire clinical data from patients' medical records to analyze trends and the frequency of occurrence of different medical conditions.
RWD - Rare Diseases Data from patients with rare diseases, can include clinical treatment, diagnosis, among others.

Show all 8 in Real World Evidence & Data 2 more

RWE/HEOR Data Analysis Analysis that helps you make sense of your RWE/HEOR data
RWE/RWD Observational Research Research method for documenting clinical, economic, and or humanistic outcomes of actual medical practice absent the constraints of a more formal experimental design. See also Pragmatic Clinical Trials.

Rare Diseases Recruitment of volunteers or study participants who have a rare disease, or specifically in the "U.S.when a chronic and enervating condition afflicts fewer than 200,000 people combined, and in the EU, when it affects...

Work with Prismatic Advisory on Scientist.com

For prices, more details, or to contact Prismatic Advisory, visit Scientist.com.